- Home
- BNC vs NVCT Comparison
BNC vs NVCT Comparison
Compare BNC & NVCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BNC | NVCT |
|---|---|---|
| Founded | N/A | 2020 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Medicinal Chemicals and Botanical Products |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 287.3M | 274.5M |
| IPO Year | N/A | 2021 |
Fundamental Metrics
Financial Performance| Metric | BNC | NVCT |
|---|---|---|
| Price | $2.50 | $9.67 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $10.00 |
| AVG Volume (30 Days) | ★ 287.0K | 113.2K |
| Earning Date | 07-24-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $0.22 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.24 | $5.55 |
| 52 Week High | $31.62 | $13.34 |
Technical Indicators
Market Signals| Indicator | BNC | NVCT |
|---|---|---|
| Relative Strength Index (RSI) | 48.76 | 46.43 |
| Support Level | $2.31 | $8.08 |
| Resistance Level | $3.05 | $9.88 |
| Average True Range (ATR) | 0.29 | 0.68 |
| MACD | 0.01 | -0.22 |
| Stochastic Oscillator | 51.85 | 12.07 |
Price Performance
Historical ComparisonAbout BNC CEA Industries Inc.
CEA Industries Inc through its subsidiary is focused on selling environmental control and other technologies and services to the Controlled Environment Agriculture ("CEA") industry. The company provides integrated mechanical, electrical, and plumbing ("MEP") engineering design, proprietary and curated environmental control equipment, and automation offerings that serve the CEA industry. The Company has one operating segment that is dedicated to the manufacture and sale of its products.
About NVCT Nuvectis Pharma Inc.
Nuvectis Pharma Inc is a biopharmaceutical company. The company is engaged in the development of precision medicines for the treatment of serious conditions of unmet medical needs in oncology. It operates with one segment, focused on the development of novel targeted small molecule therapeutics for the treatment of cancer in genetically defined patient populations. Its pipeline products include NXP800, NXP900.